Virtual Reality Vs Traditional Cognitive Training in Patients with Severe Acquired Brain Injury
Launched by ANNA ESTRANEO · Jun 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two types of rehabilitation for patients with severe acquired brain injuries (ABI). One method uses Virtual Reality (VR) technology, which creates an immersive experience to help with recovery, while the other is traditional cognitive training, which involves exercises typically done on paper or in person. The goal of the study is to see which method is more effective in helping patients improve their cognitive skills after an injury, especially since there hasn't been much research on how VR works for different types of ABI.
To participate in the trial, individuals must be between 18 and 75 years old, have a stable diagnosis, and be at least 28 days but less than 6 months post-injury. They also need to be able to complete a specific test that evaluates cognitive function. Participants can expect to engage in either VR-based rehabilitation or traditional training sessions and will be closely monitored throughout the study. This trial is currently recruiting, and it's an important step in understanding how different rehabilitation methods can help those recovering from severe brain injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • LCF ≥4 at study entry;
- • Age 18-75
- • Stable clinical diagnosis (i.e., stable LCF);
- • Time post-injury between 28 days and 6 months;
- • Ability to complete the pre-test A section of the Italian version of the Trail Making Test (TMT);
- • A pathological B-A score of the TMT according to normative data adjusted for age and education;
- • Signed informed consent by the patient or by the patient's primary caregiver.
- Exclusion Criteria:
- • Severe medical conditions that might hamper participation in the rehabilitation sessions, or influence diagnosis;
- • Previous neurodegenerative or acquired neurological diseases that affect cognitive domains (e.g., dementia)
About Anna Estraneo
Anna Estraneo is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a commitment to improving patient outcomes, the organization partners with leading healthcare professionals and institutions to design and conduct rigorous clinical trials. By prioritizing ethical standards and patient safety, Anna Estraneo strives to facilitate the development of groundbreaking therapies and medical solutions, ultimately contributing to the enhancement of healthcare practices. Through its collaborative approach and emphasis on scientific integrity, the sponsor aims to bridge the gap between research and practical application, fostering advancements that benefit both patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sant'angelo Dei Lombardi, Avellino, Italy
Milan, , Italy
Telese Terme, Benevento, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported